Finlay A Y. Quality of Life Measurement in Dermatology: a practical guide. Br J Dermatol 1997; 136: 305-314
Finlay AY. Quality of life assessments in dermatology. Seminars in Cutaneous Medicine and Surgery, 1998; 17: 291-296.
MKA Basra, AY Finlay. The family impact of skin diseases: the Greater Patient concept. Br J Dermatol 2007; 156: 929-937.
Eghlileb A. M. ; Davies E. E. G. ; Finlay A. Y. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol 2007; 156: 1245-1250.
DLQI
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol, 1994; 19: 210-216.
Lewis V L, Finlay A Y. Ten years experience of the Dermatology Life Quality Index (DLQI) J Investig Dermatol Symp Proc, 2004; 9(2):169-180.
Hongbo Y, Thomas C L, Harrison M A, Salek M S, Finlay A Y. Translating the Science of Quality of Life into Practice: What Do Dermatology Life Quality Index Scores Mean? J Invest Dermatol, 2005; 125: 659-664.
Basra MKA, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
AY Finlay. Current severe psoriasis and the Rule of Tens. Br J Dermatol 2005; 152: 861-867.
CDLQI
Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol, 1995; 132: 942-949.
Holme S A, Mann I, Sharpe J L, Dykes P J, Lewis-Jones M S, Finlay A Y. The Childrens' Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003; 148: 285-290.
Beattie P E, Lewis-Jones M S. A comparative study of impairment of quality of life in children with skin diseases and children with other chronic child diseases. Br J Dermatol 2006 155: 145-151.
PDI
Finlay AY, Kelly SE. Psoriasis - an index of disability. Clinical and Experimental Dermatology, 1987; l2: 8-ll.
Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol, 1995; 132: 236-244.
Lewis VJ, Finlay AY. Two Decades Experience of the Psoriasis Disability Index. Dermatology, 2005; 210: 261-268.
DFI
Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol, 1998; 138: 107-113.
Beattie P E, Lewis-Jones M S. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants’ Dermatitis Quality of Life Index and Dermatitis Family Impact Score. Br J Dermatol 2006; 155: 1249-1255.
Dodington SR, Basra MK, Finlay AY, Salek MS. The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application. Br J Dermatol 2013; 169: 31-46.
IDQOL
Lewis-Jones M S, Finlay A Y, Dykes P J. The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001 144: 104-10
Beattie P E, Lewis-Jones M S. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants’ Dermatitis Quality of Life Index and Dermatitis Family Impact Score. Br J Dermatol 2006; 155: 1249-1255.
CADI
Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clinical and Experimental Dermatology, 1992; 17: 1-3
Dreno B, Finlay A Y, Nocera T
et al. CADI cultural and linguist validation into French of an acne disability index. Dermatology 2004; 208: 104-108.
FDLQI
Basra MKA, Sue-Ho R, Finlay A Y. Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 2007; 156: 528-538.
Erratum: Br J Dermatol 2007;156 :791.
MKA Basra, O Edmunds, MS Salek, AY Finlay. Measurement of family impact of skin disease: further validation of the Family Dermatology Life Quality Index (FDLQI). J Eur Acad Dermatol Venereol 2008. 22: 813-821.
